Akdamar Erol R
SEC CIK 1957739 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| HCA | HCA Healthcare | Group Pres | 6,843 | — | $2.80M | 19 | 2023-02-02 | 2024-11-14 |
Most active insiders at HCA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | HAZEN SAMUEL N | CEO, Dir | — | $21.48M |
| 2 | Berres Jennifer | SVP, Chief Human Res. Off | — | $4.13M |
| 3 | McAlevey Michael R | EVP, Chief Legal, Admin Off | — | $2.75M |
| 4 | Wyatt Christopher F. | SVP, Ctrl | — | $2.02M |
| 5 | Cuffe Michael S. | EVP, Chief Clinical Off | — | $747.1K |
| 6 | Rossitto Erica | SVP, Chief Nurse Executive | — | — |
| 7 | Marks Mike A | EVP, CFO | — | — |
| 8 | Smith Andrea B | Dir | — | — |
| 9 | Foster Jon M | EVP, COO | — | — |
| 10 | Frist William R | Dir, 10% | — | — |
Akdamar Erol R made no open-market trades at HCA in the last 12 months.
Transactions 19
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-14 | 2024-11-12 | HCA | HCA Healthcare | Akdamar Erol R | Group Pres | F - Tax | $350.53 | -10.3K | 9,743 | -51% | -$3.60M |
| D | 2024-11-14 | 2024-11-12 | HCA | HCA Healthcare | Akdamar Erol R | Group Pres | M - OptEx | $68.96 | +20.0K | 20.0K | New | +$1.38M |
| D | 2024-11-14 | 2024-11-14 | HCA | HCA Healthcare | Akdamar Erol R | Group Pres | S - Sale+OE | $353.00 | -2,900 | 6,843 | -30% | -$1.02M |
| 2024-05-13 | 2024-05-09 | HCA | HCA Healthcare | Akdamar Erol R | Group Pres | G - Gift | $0.00 | -5,139 | 0 | -100% | $0 | |
| I | 2024-05-13 | 2024-05-09 | HCA | HCA Healthcare | Akdamar Erol R | Group Pres | G - Gift | $0.00 | +5,139 | 60.5K | +9% | $0 |
| 2024-02-21 | 2024-02-16 | HCA | HCA Healthcare | Akdamar Erol R | Group Pres | F - Tax | $308.55 | -2,561 | 5,139 | -33% | -$790.2K | |
| 2024-02-21 | 2024-02-16 | HCA | HCA Healthcare | Akdamar Erol R | Group Pres | A - Grant | $0.00 | +7,700 | 7,700 | New | $0 | |
| 2024-02-08 | 2024-02-06 | HCA | HCA Healthcare | Akdamar Erol R | Group Pres | G - Gift | $0.00 | -12.9K | 0 | -100% | $0 | |
| I | 2024-02-08 | 2024-02-06 | HCA | HCA Healthcare | Akdamar Erol R | Group Pres | G - Gift | $0.00 | +12.9K | 55.4K | +30% | $0 |
| D | 2023-11-15 | 2023-11-13 | HCA | HCA Healthcare | Akdamar Erol R | Group Pres | F - Tax | $229.99 | -14.0K | 12.9K | -52% | -$3.21M |
| D | 2023-11-15 | 2023-11-13 | HCA | HCA Healthcare | Akdamar Erol R | Group Pres | M - OptEx | $47.97 | +26.8K | 26.8K | New | +$1.29M |
| 2023-05-02 | 2023-04-28 | HCA | HCA Healthcare | Akdamar Erol R | Group Pres | S - Sale | $285.00 | -3,500 | 42.5K | -8% | -$997.5K | |
| 2023-05-02 | 2023-05-01 | HCA | HCA Healthcare | Akdamar Erol R | Group Pres | G - Gift | $0.00 | -42.5K | 0 | -100% | $0 | |
| I | 2023-05-02 | 2023-05-01 | HCA | HCA Healthcare | Akdamar Erol R | Group Pres | G - Gift | $0.00 | +42.5K | 42.5K | New | $0 |
| 2023-02-22 | 2023-02-17 | HCA | HCA Healthcare | Akdamar Erol R | Group Pres | A - Grant | $0.00 | +9,300 | 49.1K | +23% | $0 | |
| 2023-02-22 | 2023-02-17 | HCA | HCA Healthcare | Akdamar Erol R | Group Pres | F - Tax | $262.84 | -3,110 | 46.0K | -6% | -$817.4K | |
| D | 2023-02-06 | 2023-02-02 | HCA | HCA Healthcare | Akdamar Erol R | Group Pres | S - Sale+OE | $258.63 | -3,000 | 34.7K | -8% | -$775.9K |
| D | 2023-02-06 | 2023-02-03 | HCA | HCA Healthcare | Akdamar Erol R | Group Pres | F - Tax | $258.08 | -3,932 | 39.8K | -9% | -$1.01M |
| D | 2023-02-06 | 2023-02-03 | HCA | HCA Healthcare | Akdamar Erol R | Group Pres | M - OptEx | $45.30 | +9,000 | 43.7K | +26% | +$407.7K |
Purchase Sale Sale after option exercise All abbreviations